Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia

Published:2018-01-18 Issue:3 Volume:131 Page:289-300
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Petit Arnaud¹²^ORCID,Trinquand Amélie³⁴,Chevret Sylvie⁵,Ballerini Paola⁶,Cayuela Jean-Michel⁷,Grardel Nathalie⁸,Touzart Aurore³⁴,Brethon Benoit⁹,Lapillonne Hélène²⁶,Schmitt Claudine¹⁰,Thouvenin Sandrine¹¹,Michel Gerard¹²¹³,Preudhomme Claude⁸¹⁴,Soulier Jean¹⁵,Landman-Parker Judith¹²,Leverger Guy¹²,Macintyre Elizabeth³⁴,Baruchel André⁹,Asnafi Vahid³⁴

Affiliation:

1. Department of Pediatric Hematology and Oncology, Assistance Publique–Hôpitaux de Paris (AP-HP), Groupe Hospitalier Hôpitaux Universitaires Est Parisien (GH HUEP), Armand Trousseau Hospital, Paris, France;

2. Sorbonne Universités, UPMC Univ Paris 06, Unité Mixte de Recherche (UMR) S938, CDR Saint-Antoine, Groupe de Recherche Clinique (GRC) 07, GRC MyPAC, Paris, France;

3. Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, INSERM U1151, Paris, France;

4. Laboratory of Onco-Hematology, AP-HP, Hôpital Necker-Enfants Malades, Paris, France;

5. INSERM UMRS 1153, Université Paris Diderot, Sorbonne Paris Cité, Paris, France;

6. Laboratory of Hematology, AP-HP, GH HUEP, Armand Trousseau Hospital, Paris, France;

7. Laboratory of Hematology, Saint-Louis Hospital, AP-HP, Paris, France;

8. Laboratory of Hematology, Centre Hospitalier Régional Universitaire de Lille, Lille, France;

9. Department of Pediatric Hematology and Immunology, Robert Debré Hospital, AP-HP, Paris, France;

10. Department of Pediatric Onco-hematology, Centre Hospitalier Universitaire (CHU) de Nancy, Nancy, France;

11. Department of Pediatric Onco-hematology, CHU de Saint-Etienne, Saint-Etienne, France;

12. Department of Pediatric Hematology and Oncology, Timone Hospital, Marseilles, France;

13. Research Unit EA 3279, Aix-Marseille University, Marseilles, France;

14. U1172, INSERM, Lille, France; and

15. Department of Cytogenetics, Saint-Louis Hospital, AP-HP, Paris, France

Abstract

Key Points In pediatric T-ALL, oncogenetic markers, MRD, and WBC count are independent predictors of outcome. These factors should be used together for individual treatment stratification.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/3/289/1406246/blood778829.pdf

Reference48 articles.

1. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group;Hunger;J Clin Oncol,2012

2. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?;Pui;Blood,2012

3. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia;Smith;J Clin Oncol,1996

4. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)];Riehm;Klin Padiatr,1987

5. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL;Willemse;Blood,2002

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score-based study;2024-01-17

2. The Holy Grail of Second Complete Remission in Relapsed Pediatric T-acute Lymphoblastic Leukemia;The Hematologist;2024-01-01

3. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

4. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis;Scientific Reports;2023-08-02

5. Clinical Analysis of Pediatric T-Cell Acute Lymphoblastic Leukemia Using the MRD-Oriented Strategy System;Clinical Lymphoma Myeloma and Leukemia;2023-07